The final conference of NANOGENOTOX took place on Friday 22 February 2013 and was hosted by the propecia 1mg French Ministry of Social Affairs and discount viagra online Health, in Paris, France. It gathered around 200 participants from all over Europe and cialis testimonial beyond, including partners of the Joint Action.

The results of each WP were presented and soft viagra discussed in the morning sessions. In the afternoon, a presentation summarizing the considerations to achieve a robust method for testing the genotoxicity of MNs was made, followed by discussions with the audience (see agenda). Particular efforts were made during the panel discussion and viagra in australia for sale in the conclusions and real viagra without prescription perspectives by policy makers to examine how this method can be taken up and buy viagra followed upon within REACH or other regulatory mechanisms.

As policy makers, the OECD WPMN and the EC DG SANCO representatives confirmed that the results and get cialis online lessons coming out from NANOGENOTOX can be built upon for risk assessment and how to get cialis in canada risk management purposes. Existing frameworks and no prescription viagra guidelines are applicable for nanomaterials but some particular test guidelines have to be examined closely and cialis generic may need to be updated or replaced. The concerns identified in the NANOGENOTOX findings are shared by the EC Scientific Committee on Consumer Safety (SCCS).

To view the presentations from this meeting, click on the following pictures.


wp1               wp4


wp5               wp6


wp7               wp3







Last Updated on Friday, 01 March 2013 17:14